Sign in

CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company

NextCure, Inc.

Sign in to watch
Ticker
NXTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475231247
Phone
240-399-4900
Business address
2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
  1. 4 Open-market buy 10% owner bought 150,000 shares at $36.75 ($5,512,500)
  2. SC 13D/A Stake Beneficial Ownership Report
  3. SC 13G Stake Amended Statement of Ownership
  4. 424B4 Offering Prospectus
  5. EFFECT Other Notice of Effectiveness
  6. S-1MEF Other S-1MEF
  7. S-1/A Offering Registration Statement
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. S-1 Offering Registration Statement
  11. 10-Q Report Quarterly Report
  12. UPLOAD Other SEC-generated Letter
  13. DRS Other Draft Registration Statement
  14. 8-K Event Executive or director change · Regulation FD disclosure
  15. 10-Q Report Quarterly Report
  16. 8-K Event Regulation FD disclosure
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 17 of 20 · 400 filings